Jonathan M Peacock Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan M Peacock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan M Peacock. Jonathan M Peacock is CFO in AMGEN INC ($AMGN) and EVP & CFO in AMGEN INC ($AMGN) and Director in Kite Pharma, Inc. ($KITE) and in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and President and CEO in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Avantor, Inc. ($AVTR).
Latest Insider Trading Transactions of Jonathan M Peacock
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, AVTR, BLPH, KITE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Grant | A | 0.00 | 15,308 | 0 | 157,033 | 141.7 K to 157 K (+10.80 %) | |
Mar 01 2021 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 7,236 | 0 | 168,431 | 161.2 K to 168.4 K (+4.49 %) |
Feb 25 2020 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 11,319 | 0 | 161,195 | 149.9 K to 161.2 K (+7.55 %) |
Jan 27 2020 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 350,000 | 0 | 2,225,920 | 1.9 M to 2.2 M (+18.66 %) |
Jan 27 2020 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 350,000 | 0 | 2,225,920 | 1.9 M to 2.2 M (+18.66 %) |
May 23 2019 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Option Exercise | M | 0.00 | 1,000 | 0 | 0 | |
May 23 2019 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Buy | M | 0.00 | 117,857 | 0 | 142,001 | 24.1 K to 142 K (+488.14 %) |
May 23 2019 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 14,286 | 0 | 24,144 | 9.9 K to 24.1 K (+144.92 %) |
May 22 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.61 | 20,000 | 12,198 | 1,875,920 | 1.9 M to 1.9 M (+1.08 %) |
Jan 25 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.70 | 714,286 | 500,000 | 1,855,920 | 1.1 M to 1.9 M (+62.57 %) |
Jan 25 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 227,273 | 0 | 1,141,634 | 914.4 K to 1.1 M (+24.86 %) |
Apr 03 2018 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 99,010 | 0 | 914,361 | 815.4 K to 914.4 K (+12.14 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Sell | U | 180.00 | 67,932 | 12,227,760 | 1,807 | 69.7 K to 1.8 K (-97.41 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Gift | G | 0.00 | 635 | 0 | 69,739 | 70.4 K to 69.7 K (-0.90 %) |
Oct 03 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | P | 1.24 | 248,962 | 309,211 | 248,962 | |
Oct 03 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.00 | 248,962 | 0 | 815,351 | 566.4 K to 815.4 K (+43.96 %) |
Sep 26 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | A | 1.12 | 10,000 | 11,200 | 10,000 | |
Jun 30 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 57,972 | 0 | 566,389 | 508.4 K to 566.4 K (+11.40 %) |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 2,410 | 0 | 70,374 | 68 K to 70.4 K (+3.55 %) |
Dec 09 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | A | 0.49 | 588,373 | 288,303 | 588,373 | |
Nov 30 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | P | 0.80 | 285,715 | 228,572 | 285,715 | |
Nov 30 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.00 | 285,715 | 0 | 508,417 | 222.7 K to 508.4 K (+128.29 %) |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 1,950 | 0 | 67,964 | 66 K to 68 K (+2.95 %) |
May 18 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 1.37 | 5,000 | 6,842 | 222,702 | 217.7 K to 222.7 K (+2.30 %) |
Jan 27 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Grant | A | 0.00 | 165,975 | 0 | 217,702 | 51.7 K to 217.7 K (+320.87 %) |
Dec 17 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 2.76 | 12,800 | 35,336 | 51,727 | 38.9 K to 51.7 K (+32.88 %) |
Dec 17 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 2.72 | 7,500 | 20,400 | 38,927 | 31.4 K to 38.9 K (+23.86 %) |
Aug 20 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 5.48 | 5,000 | 27,377 | 31,427 | 26.4 K to 31.4 K (+18.92 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 | |
May 22 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 8.69 | 5,560 | 48,323 | 26,427 | 20.9 K to 26.4 K (+26.64 %) |
Mar 16 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Option Exercise | A | 10.22 | 60,000 | 613,200 | 60,000 | |
Mar 16 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Option Exercise | A | 10.22 | 16,000 | 163,520 | 16,000 | |
Feb 23 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 12.00 | 20,800 | 249,600 | 20,867 | 67 to 20.9 K (+31,044.78 %) |
Oct 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 116.32 | 13,045 | 1,517,394 | 94,414 | 107.5 K to 94.4 K (-12.14 %) |
Apr 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 104.93 | 2,721 | 285,515 | 107,312 | 110 K to 107.3 K (-2.47 %) |
Jan 30 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Grant | A | 0.00 | 7,477 | 0 | 109,950 | 102.5 K to 110 K (+7.30 %) |
Oct 29 2012 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 87.63 | 11,671 | 1,022,730 | 102,438 | 114.1 K to 102.4 K (-10.23 %) |
May 01 2012 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Grant | A | 0.00 | 8,654 | 0 | 114,027 | 105.4 K to 114 K (+8.21 %) |
Oct 31 2011 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 58.06 | 10,427 | 605,392 | 105,373 | 115.8 K to 105.4 K (-9.00 %) |
Apr 27 2011 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Option Exercise | A | 54.69 | 55,125 | 3,014,786 | 55,125 | |
Apr 27 2011 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Grant | A | 0.00 | 15,800 | 0 | 115,800 | 100 K to 115.8 K (+15.80 %) |
Oct 29 2010 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Option Exercise | A | 57.27 | 175,000 | 10,022,250 | 175,000 | |
Oct 29 2010 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Page: 1